Comparative Pharmacology
Head-to-head clinical analysis: BENZPHETAMINE HYDROCHLORIDE versus QUILLIVANT XR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENZPHETAMINE HYDROCHLORIDE versus QUILLIVANT XR.
BENZPHETAMINE HYDROCHLORIDE vs QUILLIVANT XR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Benzphetamine is a sympathomimetic amine that acts as a central nervous system stimulant. It primarily works by promoting the release of norepinephrine and dopamine from presynaptic nerve terminals in the brain, which leads to appetite suppression and increased energy expenditure.
Extended-release oral suspension formulation of methylphenidate, a central nervous system stimulant that inhibits the reuptake of dopamine and norepinephrine into presynaptic neurons, increasing their synaptic concentrations. The exact therapeutic effect in ADHD is unknown but is thought to involve dopaminergic and noradrenergic pathways in the prefrontal cortex.
25-50 mg orally once daily, may increase by 25 mg increments at weekly intervals; maximum 100 mg/day.
Initial: 25 mg orally once daily in the morning; may increase weekly in 25 mg increments based on tolerability and response. Maximum: 75 mg once daily.
None Documented
None Documented
Benzphetamine has a long elimination half-life of 10-16 hours (up to 20 hours in some individuals). Its active metabolites (amphetamine and methamphetamine) have half-lives of 10-12 hours and 9-11 hours, respectively. Steady state is reached within 3-4 days. The long half-life supports once-daily dosing but carries risk of accumulation with renal impairment.
Approximately 4 hours; extended-release formulation provides therapeutic levels for ~12 hours.
Primarily renal (approximately 70-90% of the dose excreted unchanged in urine, with the remainder as metabolites including amphetamine and methamphetamine). Fecal excretion is minimal (<5%).
Primarily renal (approximately 60% as unchanged drug); fecal excretion accounts for <5%.
Category C
Category C
CNS Stimulant
CNS Stimulant